Skip to main content
Clinical Trials/IRCT20130812014333N154
IRCT20130812014333N154
Recruiting
Phase 2

Study of the effect of Percutaneous embolization with bleomycin sclerosing in patients with symptomatic liver hemangiomas

Kermanshah University of Medical Sciences0 sites19 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Kermanshah University of Medical Sciences
Enrollment
19
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • A giant hepatic hemangioma with clear margins
  • The number of platelets is more than 100,000
  • International Ratio Normalized less than 1/5

Exclusion Criteria

  • Patients with severe ascites
  • Improper position of the hemangioma
  • Patients with hepatic or renal impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials